title: Real-world use of idarucizumab for dabigatran reversal in three cases of serious bleeding.
abstract: Bleeding is a rare complication of direct oral anticoagulant potentially associated with high mortality rates. Biological monitoring is necessary for more than 24 h after idarucizumab antidote therapy in case of bleeding with dabigatran therapy.
authors.affiliation: Hematology Department AP-HP European Hospital Georges Pompidou Paris France; Sorbonne Paris Cite Université Paris Descartes Paris France; Inserm UMR-S1140 Paris France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Gendron
authors.affiliation: Emergency Department AP-HP European Hospital Georges Pompidou Paris France.
authors.forename: Anne Laure
authors.initials: AL
authors.lastname: Feral-Pierssens
authors.affiliation: Intensive Care Unit AP-HP Beaujon Hospital Paris France.
authors.forename: Igor
authors.initials: I
authors.lastname: Jurcisin
authors.affiliation: Hematology Department AP-HP Beaujon Hospital Paris France.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: de Raucourt
authors.affiliation: Pharmacy Department AP-HP Beaujon Hospital Paris France.
authors.forename: Valerie
authors.initials: V
authors.lastname: Bouton
authors.affiliation: Hematology Department AP-HP European Hospital Georges Pompidou Paris France; Sorbonne Paris Cite Université Paris Descartes Paris France; Inserm UMR-S970 PARCC Paris France.
authors.forename: Anne Marie
authors.initials: AM
authors.lastname: Fischer
authors.affiliation: Department of Gastroenterology and Endoscopy AP-HP European Hospital Georges Pompidou Paris France.
authors.forename: Camille
authors.initials: C
authors.lastname: Lorenceau-Savale
authors.affiliation: Regional Center of Pharmacovigilance AP-HP European Hospital Georges Pompidou Paris France.
authors.forename: Agnès
authors.initials: A
authors.lastname: Lillo-Le Louët
authors.affiliation: Hematology Department AP-HP European Hospital Georges Pompidou Paris France; Sorbonne Paris Cite Université Paris Descartes Paris France; Inserm UMR-S1140 Paris France.
authors.forename: David M
authors.initials: DM
authors.lastname: Smadja
keywords: Anticoagulant; antidote; bleeding; dabigatran; idarucizumab; non‐VKA oral anticoagulants